SEVENFACT® Clinical Trials (2026): 1 Studies for Hemophilia
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 SEVENFACT® clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Hemophilia) and 17 total planned enrollment. Most recent activity: NCT05904210 (May 2024).
SEVENFACT® clinical trials at a glance: phase × recruitment status
| Phase | completed | Total |
|---|---|---|
| N/A | 1 | 1 |
All SEVENFACT® trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT05904210 | Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT® | — | completed | 17 | Laboratoire français de Fractionnement et de Biotechnologies | Nov 2023 |
SEVENFACT® clinical trials: frequently asked questions
- How many SEVENFACT® clinical trials are there?
- 1 SEVENFACT® clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is marked completed.
- Are SEVENFACT® clinical trials recruiting in 2026?
- No active SEVENFACT® trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is SEVENFACT® being studied for?
- SEVENFACT® is being studied for Hemophilia. The trials are grouped by indication on this page.
- Who sponsors SEVENFACT® clinical trials?
- The lead sponsor across the most SEVENFACT® trials is Laboratoire français de Fractionnement et de Biotechnologies. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming SEVENFACT®as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: